This Note describes the major determinants of the decisions to initiate and to fund a randomized clinical trial of extracranial/intracranial (EC/IC) bypass for stroke prevention. It describes (1) the sources of data; (2) what was known about stroke prevention in 1977; (3) the decision to initiate the EC/IC bypass trial, using a model that suggests relevance and feasibility are important factors in the decision to develop a clinical trial; (4) the peer review of the scientific merit of the grant application and the National Institute of Neurological and Communicative Disorders and Stroke Advisory Council's decision to recommend funding the trial; and (5) conclusions regarding the decisions to initiate and fund clinical trials.
This report is part of the RAND Corporation Note series. The note was a product of the RAND Corporation from 1979 to 1993 that reported other outputs of sponsored research for general distribution.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.